PT Saptausaha Gemilangindah Tbk (SAGE)
Jul 31, 2025 - SAGE was delisted (reason: acquired by SUPN)
8.68
-0.02 (-0.23%)
Inactive · Last trade price on Jul 30, 2025
Sage Therapeutics Revenue
Sage Therapeutics had revenue of 139.11M IDR in the quarter ending June 30, 2025, a decrease of -97.16%. This brings the company's revenue in the last twelve months to 9.43B, down -49.71% year-over-year. In the year 2024, Sage Therapeutics had annual revenue of 16.89B, down -23.08%.
Revenue (ttm)
9.43B IDR
Revenue Growth
-49.71%
P/S Ratio
31.67
Revenue / Employee
409,990,776 IDR
Employees
23
Market Cap
18.40M USD
Revenue Chart
* This company reports financials in IDR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.89B | -5.07B | -23.08% |
Dec 31, 2023 | 21.96B | -13.65B | -38.32% |
Dec 31, 2022 | 35.61B | 9.60B | 36.91% |
Dec 31, 2021 | 26.01B | 22.53B | 647.83% |
Dec 31, 2020 | 3.48B | 3.15B | 949.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSAGE News
- 2 months ago - Sage Therapeutics Announces Second Quarter 2025 Financial Results - Business Wire
- 3 months ago - SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE - Business Wire
- 4 months ago - Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary - GlobeNewsWire
- 4 months ago - These Analysts Revise Their Forecasts On Sage Therapeutics Following Acquisition News - Benzinga
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Connect - Accesswire
- 4 months ago - Top 3 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 4 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc. - PRNewsWire
- 4 months ago - Sage Therapeutics Stock Soars 35% After Sale to Supernus. What We Know. - Barrons